Netherlands: Recommended vaccinations
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 
Vaccination not funded by the National Health system
 
Mandatory vaccination
BirthMonthsYears
23511144591011141518606475≥ 76
Coronavirus disease (COVID-19)1
COVID-192
tuberculosis
BCG3
rotavirus infection
RV14
RV14
diphtheria
D5
D
D
D
D
d
d6
tetanus
TT5
TT
TT
TT
TT
TT
TT6
pertussis
acP5
acP
acP
acP
acp
acp6
poliomyelitis
IPV5
IPV
IPV
IPV
IPV
IPV
Haemophilus influenzae type b infection
Hib5
Hib
Hib
Hib
hepatitis B
HepB7
HepB5
HepB
HepB
HepB
pneumococcal disease
PCV8
PCV
PCV
PPSV239
meningococcal disease
MCV410
MCV411
measles
MEAS
MEAS
mumps
MUMPS
MUMPS
rubella
RUBE
RUBE
human papillomavirus infection
HPV (F)12
HPV (F/M)
influenza
IIV413

Version:


Footnotes:

  1. https://www.gezondheidsraad.nl/documenten/adviezen/2020/11/19/strategieen-voor-covid-19-vaccinatie
  2. https://www.rivm.nl/covid-19-vaccinatie
  3. vaccines only given on specific indications. please refer to https://www.kncvtbc.org/uploaded/2019/06/Handboek-Tuberculose-Nederland-2019-def.pdf for specific indications
  4. Vaccination recommended for specific risk groups from June 2020, to include: pre-terms born <37 gestation weeks; infants born with a birth weight <2500 g; infants with birth defects at increased risk for deregulation due to vomiting and/or diarrhoea. Two doses recommended at 6-9 weeks and 3 months of age. More information available at: https://lci.rivm.nl/richtlijnen/rotavirusvaccinatie
  5. Recommended only in specific circumstances, for example: infants born to a mother not vaccinated against pertussis during pregnancy or infants born to a mother infected with Hepatitis B
  6. Recommended for pregnant women from 22 weeks gestation
  7. Offered to infants born to a mother infected with hepatitis B
  8. https://www.rivm.nl/en/pneumococci/information-for-policy-makers
  9. Implementation starting from fall 2020. Vaccination recommended for healthy adults aged 60 to 75 years. First dose at 60 years followed by booster doses every 5 years with a last dose at 75 years. More information available at: https://www.rivm.nl/pneumokokken/pneumokokkenvaccinatie-voor-ouderen https://www.rivm.nl/en/pneumococci/information-for-policy-makers
  10. Replaced MenC in 2018.
  11. Introduced in 2018
  12. 2-valent. Two dose schedule at 0 and 6 months. Gender neutral (boys and girls) vaccination offered starting from 2022.
  13. https://www.rivm.nl/en/flu-and-flu-jab


More information available at:
https://rijksvaccinatieprogramma.nl/vaccinaties/vaccinatieschema



----------------------------------------------------------------------------------------------
More information on vaccination available from:

Ministry of Health http://www.rijksoverheid.nl/onderwerpen/vaccinaties

RIVM http://www.rivm.nl/Onderwerpen/Onderwerpen/R/Rijksvaccinatieprogramma

The National Immunisation Programme in the Netherlands: https://rijksvaccinatieprogramma.nl/english
----------------------------------------------------------------------------------------------


MAJOR HISTORICAL CHANGES

2002 (September): MenC vaccination was introduced, with a catch-up campaign for all 14 months-18 years.

2003 (March): Hib was added to DTwP and IPV in a combined vaccine at 2, 3, 4 and 11 months.

2003 (March): HepB vaccination was introduced for children of parents from a hepatitis B endemic area.

2005 (January): Accellular pertussis replaced whole-cell pertussis at 2, 3, 4 and 11 months.

2006 (January): A birth dose of HepB was introduced for children born to mothers infected with hepatitis B.

2006 (June): Pneumococcal vaccination was introduced at 2, 3, 4 and 11 months.

2009 (September): HPV vaccination was introduced for girls only with three doses (0, +1 and +6 months), starting with birth cohort 1997 (additional catch-up campaign for birth cohorts 1993-1996)

2011 (May): Pneumococcal vaccination changed from 7-valent to 10-valent vaccine (for children born from 1-3-2011)

2011 (October): Transition to universal HepB vaccination (for children born from 1-8-2011), given in a combined vaccine with DTaP, IPV and Hib

2013 (November): Change to pneumococcal recommendation: 2+1 schedule instead of 3+1 schedule

2014 (January): Change to HPV recommendation. For girls under age 15, Cervarix can be adminsitered in a 2 dose schedule instead of 3 previously.
The 0-1-6-schedule in under 15's is replaced by two doses in a 0-6-schedule.
Further information for those that are currently completing HPV vaccination is available from www.prikkenteller.nl

2018: May 2018, MenC vaccination at 14 months of age has been replaced by MenACWY. From October 2018, 13-14 year olds (in the year they turn 14 years) have been vaccinated with MenACWY vaccination. A catch-up campaign was conducted in 2018-2019 targeting 14-18 year olds.

From 2021: HPV vaccination will be extended to boys

----------------------------------------------------------------------------------------------

Date of last update: 04 Nov 2021

----------------------------------------------------------------------------------------------